Nasdaq

Integra LifeSciences Announces First Patient Enrollment in Acclarent AERA Pediatric Registry for Eustachian Tube Dysfunction in Children

Integra LifeSciences Holding Corporation has announced the enrollment of the first patient in the Acclarent AERA Pediatric Registry, which aims to evaluate the real-world use of the AERA Eustachian ...
Nasdaq

Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry

PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first ...
News Medical

Johnson & Johnson announces FDA clearance to expand indication for Acclarent AERA device

Johnson & Johnson Medical Devices Companies today announced that Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat (ENT) technologies, has received clearance from the U.S.
Hosted on MSN

IART Stock May Rise on First Enrollment in AERA Pediatric Registry

Integra LifeSciences Holding Corporation IART recently announced the enrollment of the first patient in the Acclarent AERA Pediatric Registry — a multi-center observational registry — designed to ...
MyCentralJersey

Heartbeats: RWJ physician first in NJ to perform ear procedure

Dr. Michael S. Goldrich, board-certified otolaryngologist at University Otolaryngology Associates and the Department of Otolaryngology at Robert Wood Johnson University Hospital (RWJUH) in New ...
Finanznachrichten

Integra LifeSciences Holdings Corporation: Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA Pediatric Registry

PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first ...